Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Accumulated Deficit
Treasury Stock
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   18,045,029        
Beginning balance at Dec. 31, 2023 $ 49,383 $ 18 $ 118,694 $ (5,029) $ (64,000) $ (300)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares and treasury shares for cash, net of offering cost (in shares)   1,033,500        
Issuance of common shares and treasury shares for cash, net of offering cost 4,624   4,624      
Stock-based compensation 3,021   3,021      
Unrealized gain (loss) on marketable securities 103         103
Net loss (19,005)     (19,005)    
Ending balance (in shares) at Sep. 30, 2024   19,078,529        
Ending balance at Sep. 30, 2024 38,126 $ 18 126,339 (24,034) (64,000) (197)
Beginning balance (in shares) at Jun. 30, 2024   19,078,529        
Beginning balance at Jun. 30, 2024 44,076 $ 18 125,703 (17,447) (64,000) (198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 636   636      
Unrealized gain (loss) on marketable securities 1         1
Net loss (6,587)     (6,587)    
Ending balance (in shares) at Sep. 30, 2024   19,078,529        
Ending balance at Sep. 30, 2024 $ 38,126 $ 18 126,339 (24,034) (64,000) (197)
Beginning balance (in shares) at Dec. 31, 2024 29,874,029 29,874,029        
Beginning balance at Dec. 31, 2024 $ 7,353 $ 23 129,921 (58,393) (64,000) (198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares and treasury shares for cash, net of offering cost (in shares)   11,315,000        
Issuance of common shares and treasury shares for cash, net of offering cost 3,558 $ 6 (10,805)   14,357  
Issuance of common stock as commitment fee for future financing (in shares)   352,176        
Issuance of warrants in conjunction with debt issuance 1,260   1,260      
Reclassification of liability classified warrants to equity 575   575      
Stock-based compensation 1,460   1,460      
Net loss $ (7,345)     (7,345)    
Ending balance (in shares) at Sep. 30, 2025 41,541,205 41,541,205        
Ending balance at Sep. 30, 2025 $ 6,861 $ 29 122,411 (65,738) (49,643) (198)
Beginning balance (in shares) at Jun. 30, 2025   41,541,205        
Beginning balance at Jun. 30, 2025 11,436 $ 29 120,145 (58,899) (49,643) (196)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of warrants in conjunction with debt issuance 1,260   1,260      
Reclassification of liability classified warrants to equity 575   575      
Stock-based compensation 431   431      
Unrealized gain (loss) on marketable securities (2)         (2)
Net loss $ (6,839)     (6,839)    
Ending balance (in shares) at Sep. 30, 2025 41,541,205 41,541,205        
Ending balance at Sep. 30, 2025 $ 6,861 $ 29 $ 122,411 $ (65,738) $ (49,643) $ (198)